Colorado State University researchers use their established expertise, from rotaviruses to blood pathogens, to address the emerging SARS-CoV-2 virus.
With the emergence of COVID-19, the Dean lab shifted their existing vaccine platform for feline coronavirus to develop a human coronavirus vaccine.
Researchers led by Gregg Dean are developing a coronavirus vaccine which could be consumed orally, which would make the medication drastically more accessible to people all around the world.
Colorado State University now has 25 projects campus-wide to fight the coronavirus pandemic.
A CSU research team is pursuing a vaccine that would thwart the novel coronavirus using a genetically modified form of the well-known probiotic, Lactobacillus acidophilus.
Gregg Dean is leading vaccination development for feline enteric coronavirus (FECV), before it can cause feline infectious peritonitis (FIP).
Morris Animal Foundation-funded researchers at Colorado State University are working on an oral vaccine for feline enteric coronavirus (FECV).